Sustained low rotavirus activity and hospitalisation rates in the post-vaccination era in Belgium, 2007 to 2014

Eurosurveillance

Volumn 21, Issue 27, 2016, Pages

  Sabbe, Martine ^a   Berger, N ^a,b   Blommaert, A ^c,d   Ogunjimi, B ^c,d   Grammens, T ^a   Callens, M ^e   Van Herck, K ^c,f   Beutels, P ^c,g   Van Damme, P ^c   Bilcke, J ^c  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d HASSELT UNIVERSITY   (Belgium)

^e National Alliance of Christian Sickness Funds   (Belgium)

^f GHENT UNIVERSITY   (Belgium)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

AGE DISTRIBUTION; ARTICLE; BELGIUM; CHILD; DATA BASE; DEATH; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; INFANT; LABORATORY TEST; NEWBORN; POST EXPOSURE PROPHYLAXIS; PRESCHOOL CHILD; ROTAVIRUS; ROTAVIRUS INFECTION; SCHOOL CHILD; VACCINATION; VIRAL GASTROENTERITIS; CLINICAL TRIAL; EPIDEMIOLOGY; FEMALE; GASTROENTERITIS; HOSPITAL MORTALITY; INCIDENCE; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; MALE; MORTALITY; PREVENTIVE HEALTH SERVICE; RISK FACTOR; ROTAVIRUS INFECTIONS; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TREATMENT OUTCOME; UTILIZATION; VIROLOGY; VIRUS LOAD;

BELGIUM; CHILD; CHILD, PRESCHOOL; FEMALE; GASTROENTERITIS; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; LONGITUDINAL STUDIES; MALE; RISK FACTORS; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SURVIVAL RATE; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84978924593     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2016.21.27.30273     Document Type: Article

References (46)

1. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD, WHO-coordinated Global Rotavirus Surveillance Network. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(2):136-41. DOI: 10.1016/S1473-3099(11)70253-5
2. Payne DC, Wikswo M, Parashar UD. Centers for Disease Control and Prevention (CDC). Manual for the surveillance of vaccinepreventable diseases. Chapter 13: Rotavirus.Atlanta: CDC; 2014. Available from: http://www.cdc.gov/vaccines/pubs/survmanual/chpt13-rotavirus.html
3. Bilcke J, Van Damme P, Van Ranst M, Hens N, Aerts M, Beutels P. Estimating the incidence of symptomatic rotavirus infections: a systematic review and meta-analysis. PLoS One. 2009;4(6):e6060. DOI: 10.1371/journal.pone.0006060
4. Bilcke J, Van Damme P, De Smet F, Hanquet G, Van Ranst M, Beutels P. The health and economic burden of rotavirus disease in Belgium. Eur J Pediatr. 2008;167(12):1409-19. DOI: 10.1007/s00431-008-0684-3
5. Belgisch Centrum voor Farmacotherapeutische Informatie - Centre Belge d’Information Pharmacothérapeutique (BCFICBIP). [Belgian Center for Pharmacotherapeutic Information]. Gecommentarieerd Geneesmiddelenrepertorium. Vaccin tegen rotavirus. [Commented Repertory of medicines. Rotavirus vaccine]. [Accessed 6 Aug 2015]. Dutch. Available from: http://www.bcfi.be/GGR/MPG/MPG_LAAJ.cfm
6. Hanquet G, Ducoffre G, Vergison A, Neels P, Sabbe M, Van Damme P, et al. Impact of rotavirus vaccination on laboratory confirmed cases in Belgium. Vaccine. 2011;29(2930):4698-703. DOI: 10.1016/j.vaccine.2011.04.098
7. Raes M, Strens D, Vergison A, Verghote M, Standaert B. Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium. Pediatr Infect Dis J. 2011;30(7):e120-5. DOI: 10.1097/INF.0b013e318214b811
8. Zeller M, Rahman M, Heylen E, De Coster S, De Vos S, Arijs I, et al. Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. Vaccine. 2010;28(47):7507-13. DOI: 10.1016/j.vaccine.2010.09.004
9. Braeckman T, Van Herck K, Meyer N, Pirçon JY, Soriano-Gabarró M, Heylen E, et al., RotaBel Study Group. Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study. BMJ. 2012;345(aug08 1):e4752. DOI: 10.1136/bmj.e4752
10. Braeckman T, Theeten H, Lernout T, Hens N, Roelants M, Hoppenbrouwers K, et al. Rotavirus vaccination coverage and adherence to recommended age among infants in Flanders (Belgium) in 2012. Euro Surveill. 2014;19(20):20806. DOI: 10.2807/1560-7917.ES2014.19.20.20806
11. Robert E, Dramaix M, Swennen B. Vaccination coverage for infants: cross-sectional studies in two regions of Belgium. Biomed Res Int. 2014;2014:838907.
12. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. Vienna: 2014. Available from: http://www.R-project.org
13. Directorate General Statistics and Economic Information. Statistics Belgium. [Accessed 30 Jan 2015]. Available from: http://statbel.fgov.be/
14. Agentschap Zorg en Gezondheid. [Agency for Care and Health]. Vaccinnet. [Accessed 30 Jan 2015]. Dutch. Available from: https://www.vaccinnet.be/Vaccinnet/welkom.do
15. Scientific Institute of Public Health B. Sentinel Laboratory Network. [Accessed: 30 Jan 2015]. Available from: https://epidemio.wiv-isp.be/ID/Surveillance/Pages/sentinelLabs.aspx
16. Mutualiteit C. Landsbond der Christelijke Mutualiteiten. Jaarverslag 2013. [National Alliance of Christian Sickness Funds. Annual Report 2013]. [Accessed: 30 Jan 2015]. Dutch. Available from: http://www.cm.be/binaries/Jaarverslag-2013_tcm375-130990.pdf
17. Centers for Disease Control and Prevention (CDC). International classification of diseases, ninth revision, clinical modification (ICD-9-CM). Atlanta: CDC; 2010. Available from: http://www.cdc.gov/nchs/icd/icd9cm.htm
18. World Health Organization (WHO). International statistical classification of diseases and related health problems. 10th Revision. Volume 2. Instruction manual. 2010 ed. Geneva: WHO; 2011. Available from: http://www.who.int/classifications/icd/ICD10Volume2_en_2010.pdf
19. Drieskens S, van Oyen H, Tafforeau J, Lafontaine MF. Interactive analysis of Belgian vital statistics on the Internet. Med Inform Internet Med. 2006;31(4):237-45. DOI: 10.1080/14639230500512499
20. Afdeling Informatie en Zorgberoepen. Cijfers sterfte. [Departement of Information and Care professions]. Accessed: 30 Jan 2015. Dutch. Available from: http://www.zorg-engezondheid.be/cijfers/
21. European Centre for Disease Prevention and Control (ECDC). Impact of rotavirus vaccination - Generic study protocol. Stockholm: ECDC; 2013.
22. Tate JE, Haynes A, Payne DC, Cortese MM, Lopman BA, Patel MM, et al. Trends in national rotavirus activity before and after introduction of rotavirus vaccine into the national immunization program in the United States, 2000 to 2012. Pediatr Infect Dis J. 2013;32(7):741-4. DOI: 10.1097/INF.0b013e31828d639c
23. Hanquet G, Valenciano M, Simondon F, Moren A. Vaccine effects and impact of vaccination programmes in postlicensure studies. Vaccine. 2013;31(48):5634-42. DOI: 10.1016/j.vaccine.2013.07.006
24. Fieller EC. The biological standardization of insulin. Suppl to J R Statist Soc. 1940;7:1-64.
25. Panozzo CA, Becker-Dreps S, Pate V, Jonsson Funk M, Stürmer T, Weber DJ, et al. Patterns of rotavirus vaccine uptake and use in privately-insured US infants, 2006-2010. PLoS One. 2013;8(9):e73825. DOI: 10.1371/journal.pone.0073825
26. Krishnarajah G, Landsman-Blumberg P, Eynullayeva E. Rotavirus vaccination compliance and completion in a Medicaid infant population. Vaccine. 2015;33(3):479-86. DOI: 10.1016/j.vaccine.2014.06.059
27. Krishnarajah G, Davis EJ, Fan Y, Standaert BA, Buikema AR. Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United States. Vaccine. 2012;30(24):3717-22. DOI: 10.1016/j.vaccine.2011.12.077
28. Forster J, Guarino A, Parez N, Moraga F, Román E, Mory O, et al., Rotavirus Study Group. Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis among European children younger than 5 years of age. Pediatrics. 2009;123(3):e393-400. DOI: 10.1542/peds.2008-2088
29. Soriano-Gabarró M, Mrukowicz J, Vesikari T, Verstraeten T. Burden of rotavirus disease in European Union countries. Pediatr Infect Dis J. 2006;25(1) Suppl;S7-11. DOI: 10.1097/01.inf.0000197622.98559.01
30. Van Damme P, Giaquinto C, Huet F, Gothefors L, Maxwell M, Van der Wielen M, REVEAL Study Group. Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study. J Infect Dis. 2007;195(1) Suppl 1;S4-16. DOI: 10.1086/516714
31. Bilcke J, Van Damme P, Beutels P. Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and “no medical care” disease impact in Belgium. Med Decis Making. 2009;29(1):33-50. DOI: 10.1177/0272989X08324955
32. Soares-Weiser K, Maclehose H, Bergman H, Ben-Aharon I, Nagpal S, Goldberg E, et al. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev. 2012;11:CD008521.
33. Patel MM, Glass R, Desai R, Tate JE, Parashar UD. Fulfilling the promise of rotavirus vaccines: how far have we come since licensure? Lancet Infect Dis. 2012;12(7):561-70. DOI: 10.1016/S1473-3099(12)70029-4
34. Atchison C, Lopman B, Edmunds WJ. Modelling the seasonality of rotavirus disease and the impact of vaccination in England and Wales. Vaccine. 2010;28(18):3118-26. DOI: 10.1016/j.vaccine.2010.02.060
35. Hahné S, Hooiveld M, Vennema H, van Ginkel A, de Melker H, Wallinga J, et al. Exceptionally low rotavirus incidence in the Netherlands in 2013/14 in the absence of rotavirus vaccination. Euro Surveill. 2014;19(43):20945. DOI: 10.2807/1560-7917.ES2014.19.43.20945
36. Royal Meteorological Institute of Belgium (RMI). [Accessed: 30 March 2015]. Dutch. Available from: http://www.meteo.be/meteo/view/en/65239-Home.htm
37. Elam-Evans LD, Yankey D, Singleton JA, Kolasa M, Centers for Disease Control and Prevention (CDC). National, state, and selected local area vaccination coverage among children aged 19-35 months - United States, 2013. MMWR Morb Mortal Wkly Rep. 2014;63(34):741-8.
38. Bilcke J, Chapman R, Atchison C, Cromer D, Johnson H, Willem L, et al. Quantifying Parameter and Structural Uncertainty of Dynamic Disease Transmission Models Using MCMC: An Application to Rotavirus Vaccination in England and Wales. Med Decis Making. 2015;35(5):633-47. DOI: 10.1177/0272989X14566013
39. Pitzer VE, Atkins KE, de Blasio BF, Van Effelterre T, At chison CJ, Harris JP, et al. Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic models. PLoS One. 2012;7(8):e42320. DOI: 10.1371/journal.pone.0042320
40. Paulke-Korinek M, Kollaritsch H, Aberle SW, Zwazl I, Schmidle-Loss B, Vécsei A, et al. Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria. Vaccine. 2013;31(24):2686-91. DOI: 10.1016/j.vaccine.2013.04.001
41. Matthijnssens J, Bilcke J, Ciarlet M, Martella V, Bányai K, Rahman M, et al. Rotavirus disease and vaccination: impact on genotype diversity. Future Microbiol. 2009;4(10):1303-16. DOI: 10.2217/fmb.09.96
42. Sudarmo SM, Shigemura K, Athiyyah AF, Osawa K, Wardana OP, Darma A, et al. Genotyping and clinical factors in pediatric diarrhea caused by rotaviruses: one-year surveillance in Surabaya, Indonesia. Gut Pathog. 2015;7(1):3. DOI: 10.1186/s13099-015-0048-2
43. Cascio A, Vizzi E, Alaimo C, Arista S. Rotavirus gastroenteritis in Italian children: can severity of symptoms be related to the infecting virus? Clin Infect Dis. 2001;32(8):1126-32. DOI: 10.1086/319744
44. Matthijnssens J, Zeller M, Heylen E, De Coster S, Vercauteren J, Braeckman T, et al., RotaBel study group. Higher proportion of G2P[4] rotaviruses in vaccinated hospitalized cases compared with unvaccinated hospitalized cases, despite high vaccine effectiveness against heterotypic G2P[4] rotaviruses. Clin Microbiol Infect. 2014;20(10):O702-10. DOI: 10.1111/1469-0691.12612
45. Velázquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med. 1996;335(14):1022-8. DOI: 10.1056/NEJM199610033351404
46. Paul A, Gladstone BP, Mukhopadhya I, Kang G. Rotavirus infections in a community based cohort in Vellore, India. Vaccine. 2014;32(Suppl 1):A49-54. DOI: 10.1016/j.vaccine.2014.03.039